125 related articles for article (PubMed ID: 36007776)
1. Midterm Outcomes of Endovascular Therapy for TASC II D Femoropopliteal Lesions with Critical Limb Ischemia: A Retrospective Analysis.
Liu P; Zheng LH; He XQ; Yang Y; Zhang LK; Zhang L; Zhang F
Ann Vasc Surg; 2023 Jan; 88():182-190. PubMed ID: 36007776
[TBL] [Abstract][Full Text] [Related]
2. Mid-Term Outcomes of Endovascular Treatment for TASC-II D Femoropopliteal Occlusive Disease with Critical Limb Ischemia.
Torres-Blanco Á; Edo-Fleta G; Gómez-Palonés F; Molina-Nácher V; Ortiz-Monzón E
Cardiovasc Intervent Radiol; 2016 Mar; 39(3):344-52. PubMed ID: 26202389
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study.
Veraldi GF; Mezzetto L; Macrì M; Criscenti P; Corvasce A; Poli R
Ann Vasc Surg; 2018 Feb; 47():179-187. PubMed ID: 28943491
[TBL] [Abstract][Full Text] [Related]
4. Endovascular treatment of TransAtlantic Inter-Society Consensus II D femoropopliteal lesions in patients with critical limb ischemia.
Biagioni RB; Brandão GD; Biagioni LC; Nasser F; Burihan MC; Ingrund JC
J Vasc Surg; 2019 May; 69(5):1510-1518. PubMed ID: 30611581
[TBL] [Abstract][Full Text] [Related]
5. Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease.
Tran K; Ullery BW; Kret MR; Lee JT
Ann Vasc Surg; 2017 Jan; 38():90-98. PubMed ID: 27554688
[TBL] [Abstract][Full Text] [Related]
6. The success of endovascular therapy for all TransAtlantic Society Consensus graded femoropopliteal lesions.
Han DK; Shah TR; Ellozy SH; Vouyouka AG; Marin ML; Faries PL
Ann Vasc Surg; 2011 Jan; 25(1):15-24. PubMed ID: 20932714
[TBL] [Abstract][Full Text] [Related]
7. Shared and differential factors influencing restenosis following endovascular therapy between TASC (Trans-Atlantic Inter-Society Consensus) II class A to C and D lesions in the femoropopliteal artery.
Iida O; Takahara M; Soga Y; Suzuki K; Hirano K; Kawasaki D; Shintani Y; Suematsu N; Yamaoka T; Nanto S; Uematsu M
JACC Cardiovasc Interv; 2014 Jul; 7(7):792-8. PubMed ID: 25060024
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Results of Endovascular Treatment with Nitinol Stents for Femoropopliteal TASC II C and D Lesions.
Kluckner M; Nierlich P; Hitzl W; Aschacher T; Gratl A; Wipper S; Aspalter M; Moussalli H; Linni K; Enzmann FK
Medicina (Kaunas); 2022 Sep; 58(9):. PubMed ID: 36143902
[No Abstract] [Full Text] [Related]
9. Cryoplasty as endovascular treatment in the femoropopliteal region: hemodynamic results and follow-up at one year.
Gonzalo B; Solanich T; Bellmunt S; Herranz C; González E; Arnedo G; Muñoz G; Florit S; Hospedales J; Lloret MD; Vallespín J; Giménez A
Ann Vasc Surg; 2010 Jul; 24(5):680-5. PubMed ID: 20409679
[TBL] [Abstract][Full Text] [Related]
10. Midterm Outcomes After Infrapopliteal Interventions in Patients With Critical Limb Ischemia Based on the TASC II Classification of Below-the-Knee Arteries.
Singh GD; Brinza EK; Hildebrand J; Waldo SW; Foley TR; Laird JR; Armstrong EJ
J Endovasc Ther; 2017 Jun; 24(3):321-330. PubMed ID: 28421855
[TBL] [Abstract][Full Text] [Related]
11. Primary stenting for TASC C and D femoropopliteal lesions: one-year results from a multicentric trial on 203 patients.
Brouillet J; Deloose K; Goueffic Y; Poirier M; Midy D; Caradu C; Ducasse E
J Cardiovasc Surg (Torino); 2018 Jun; 59(3):392-404. PubMed ID: 27272981
[TBL] [Abstract][Full Text] [Related]
12. One-year clinical outcome after primary stenting for Trans-Atlantic Inter-Society Consensus (TASC) C and D femoropopliteal lesions (the STELLA "STEnting Long de L'Artère fémorale superficielle" cohort).
Davaine JM; Azéma L; Guyomarch B; Chaillou P; Costargent A; Patra P; Lambert G; Gouëffic Y
Eur J Vasc Endovasc Surg; 2012 Oct; 44(4):432-41. PubMed ID: 22920949
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of endovascular interventions for TASC II B and C femoropopliteal lesions.
Baril DT; Marone LK; Kim J; Go MR; Chaer RA; Rhee RY
J Vasc Surg; 2008 Sep; 48(3):627-33. PubMed ID: 18727966
[TBL] [Abstract][Full Text] [Related]
14. Endovascular interventions for TransAtlantic InterSociety Consensus II C and D femoropopliteal lesions.
Yin MY; Jiang ME; Huang XT; Lu M; Lu XW; Huang Y; Li WM
Chin Med J (Engl); 2013 Feb; 126(3):415-20. PubMed ID: 23422099
[TBL] [Abstract][Full Text] [Related]
15. Endovascular interventions for TASC II D femoropopliteal lesions.
Baril DT; Chaer RA; Rhee RY; Makaroun MS; Marone LK
J Vasc Surg; 2010 Jun; 51(6):1406-12. PubMed ID: 20385464
[TBL] [Abstract][Full Text] [Related]
16. Endovascular Therapy for Femoropopliteal Artery Disease and Association of Risk Factors With Primary Patency: The Implication of Critical Limb Ischemia and TASC II C/D Disease.
Nishibe T; Yamamoto K; Seike Y; Ogino H; Nishibe M; Koizumi J; Dardik A
Vasc Endovascular Surg; 2015 Nov; 49(8):236-41. PubMed ID: 26574486
[TBL] [Abstract][Full Text] [Related]
17. Endovascular Treatment of Severely Calcified Femoropopliteal Lesions Using the "Pave-and-Crack" Technique: Technical Description and 12-Month Results.
Dias-Neto M; Matschuck M; Bausback Y; Banning-Eichenseher U; Steiner S; Branzan D; Staab H; Varcoe RL; Scheinert D; Schmidt A
J Endovasc Ther; 2018 Jun; 25(3):334-342. PubMed ID: 29557221
[TBL] [Abstract][Full Text] [Related]
18. Clinical Outcome of Drug-Eluted Stenting (Zilver PTX) in Patients With Femoropopliteal Occlusive Disease a Single Center Experience.
AbuRahma AF; Beasley M; AbuRahma ZT; Davis M; Adams E; Dean LS; Shapiro J; Scott G; Davis E
J Endovasc Ther; 2022 Jun; 29(3):350-360. PubMed ID: 34622706
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of embolic events in patients undergoing endovascular femoropopliteal interventions with or without embolic protection devices.
Mendes BC; Oderich GS; Fleming MD; Misra S; Duncan AA; Kalra M; Cha S; Gloviczki P
J Vasc Surg; 2014 Feb; 59(2):359-367.e1. PubMed ID: 24461861
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of femoropopliteal stenting. Results of a prospective study.
Schönefeld E; Torsello G; Osada N; Herten M; Bisdas T; Donas KP
J Cardiovasc Surg (Torino); 2013 Oct; 54(5):617-23. PubMed ID: 24002391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]